SCABIES TANISI OLAN BIREYLERDE İLAÇ UYUMU VE YAŞAM KALİTESİNİN BELİRLENMESİ

Year 2023, , 6 - 10, 30.04.2023

Aslan Yürekli , Songül Duran

https://doi.org/10.52831/kjhs.1168654

Cited By: 2

Abstract

Amaç: Bu araştırma, scabies tanısı alan bireylerde sosyodemografik özelliklerin cilt yaşam kalitesi ve tıbbi uyum ile ilişkisini belirlemek amacıyla yapıldı.
Yöntem: Araştırmaya scabies tanısı konulan ve tedavi sonrası kontrole çağrılan hastalar dahil edildi (87 kişi). Çalışmada sosyodemografik soru formu ve Skindex-16 Ölçeği (Skindex-16) ve İlaca Uyum Ölçeği kullanıldı. Veriler bilgisayar ortamında SPSS (Statistical Package for Social Sciences) paket programı kullanılarak değerlendirildi ve anlamlılık düzeyi p<0.05 olarak kabul edildi. Verilerin değerlendirilmesinde yüzde ve ortalama, gruplar arası karşılaştırmalarda student t-testi ve one-way ANOVA, değişkenler arasındaki ilişkinin değerlendirilmesinde korelasyon analizleri kullanıldı.
Bulgular: Çalışmada bireylerin yaşam kalitesi orta düzeyde saptandı. İlaca uyum ölçeğinden aldıkları puan ise iyi düzeydeydi. Çocuğu olanlarda, mikroskopta paraziti görmeyenlerde ve evde başka bireylerde scabies tanısı olanlarda yaşam kalitesi puanı daha düşük düzeyde bulundu. Yaşam kalitesi puanının ilaca uyum puanı ile negatif yönde; hastalık süresi ile pozitif yönde istatiksel olarak anlamlı bir ilişkisi vardı. İstatistiksel testlerin anlamlılık düzeyi için p<0,05 değeri kabul edildi.
Sonuç: Bu hastalarda psikososyal destek ve psikoterapötik müdahalelerin bireylerde yaşam kalitesine olumlu etki edeceği düşünülmektedir. Bireylere ilaca uyum konusunda eğitim verilmesinin önemli olduğu düşünülmektedir.

Keywords

Dermatoloji, Scabies, Tedaviye Uyum, Yaşam Kalitesi

Thanks

Araştırmaya katılan hastalara teşekkür ederiz.

DETERMINATION OF DRUG COMPLIANCE AND QUALITY OF LIFE IN INDIVIDUALS DIAGNOSED WITH SCABIES

Abstract

Objective: This study was conducted to determine the relationship between sociodemographic characteristics, skin quality of life and medical compliance in individuals diagnosed with scabies.
Method: Patients diagnosed with scabies and called for follow-up after treatment were included in the study (87 people). A sociodemographic questionnaire and Skindex-16 Scale (Skindex-16) and Medication Adherence Report Scale were used in the study. The data were evaluated using the SPSS (Statistical Package for Social Sciences) package program and the level of significance was accepted as p<0.05. Percentage and mean were used to evaluate the data, student t-test and one-way ANOVA were used for comparisons between groups, and correlation analyzes were used to evaluate the relationship between variables.
Results: In the study, the quality of life of the individuals was found to be moderate. The scores they got from the drug compliance scale were at a good level. The quality of life score was found to be lower in those who had children, did not see the parasite under the microscope, and were diagnosed with scabies in other individuals at home. There is a statistically significant relationship between the quality of life score and the drug compliance score in the negative direction and the disease duration in the positive direction. A p<0.05 value was accepted for the significance level of statistical tests.
Conclusion: It is thought that psychosocial support and psychotherapeutic interventions will positively affect the quality of life of these patients. It is considered important to provide education to individuals about drug compliance.

Keywords

Dermatology, Scabies, Compliance with Treatment, Quality of Life

References

• Boateng LA. Healthcare-seeking behaviour in reporting of scabies and skin infections in Ghana: A review of reported cases. Trans R Soc Trop Med Hyg. 2020;114:830-837.
• Azene AG, Aragaw AM, Wassie GT. Prevalence and associated factors of scabies in Ethiopia: Systematic review and Meta-analysis. BMC Infect Dis. 2020;20(380):1-10.
• Özden MG, Ertürk K, Kartal SP, et al. An extraordinary outbreak of scabies in Turkey. J Eur Acad Dermatology Venereol. 2020;34:e755-853.
• De Lucia M, Potestio L, Costanzo L, Fabbrocini G, Gallo L. Scabies outbreak during COVID-19: An Italian experience. Int J Dermatol. 2021:1-2.
• Alharthi AS, Alsofyani MA, Alharthi WK, Alsalmi SA, Altalhi AS, Alswat KA. Assessment of knowledge and fear of scabies in a Saudi population. J Multidiscip Healthc. 2021;14:1361-1371.
• Widaty S, Miranda E, Cornain EF, Rizky LA. Scabies: update on treatment and efforts for prevention and control in highly endemic settings. J Infect Dev Ctries. 2022;16(2):244-251.
• Ong C, Vasanwala F. Infected with scabies again? focus in management in long-term care facilities. Diseases. 2018;7(3):2-12.
• Sunderkötter C, Aebischer A, Neufeld M, et al. Increase of scabies in Germany and development of resistant mites? Evidence and consequences. JDDG - J Ger Soc Dermatology. 2019;17(1):15-23.
• De Sainte Marie B, Mallet S, Gaudy-Marqueste C, et al. Gales en échec de traitement : étude observationnelle. Ann Dermatol Venereol [Internet]. 2016;143:9-15.
• Menaldi SLS, Surya D, Marissa M. Impact of scabies on Indonesian public boarding school students’ quality of life : A mixed-method analysis. J Gen Proced Dermatol Venereol Indones. 2021;5(2):74-78.
• Chowdhry S, Sheoran P, D’souza P, Yadav MK, Rathore S. Assessment of the quality of life in patients with scabies in an urban Tertiary Care Centre in North India. Serbian J Dermatology Venereol. 2020;12(2):41-46.
• Worth C, Heukelbach J, Fengler G, Walter B, Liesenfeld O, Feldmeier H. Impaired quality of life in adults and children with scabies from an impoverished community in Brazil. Int J Dermatol. 2012;51:275-282.
• Bilal K, Othman S, Asaad Y. Quality of life in patients with scabies in Erbil, Iraq. Zanco J Med Sci. 2021;25(3):638-648.
• Bindushree R, Hosthota A. A study of clinical profile and quality of life in patients with scabies. IJORD. 2021;7(4):508-512.
• Talaga-Ćwiertnia K. Sarcoptes infestation. What is already known, and what is new about scabies at the beginning of the third decade of the 21st century? Pathogens. 2021;10(868):2-12.
• Faul F, Erdfelder E, Buncher A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175-191.
• Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: Reliability, validity, and responsiveness. J Invest Dermatol. 1996;107(5):707-713.
• Aksu AEK, Saraçoǧlu ZN, Sabuncu I, Chren MM, Tozun M. Skindeks-16′nin Türkçe uyarlamasinin geçerliǧi ve güvenirliǧi. Turkderm Deri Hast ve Frengi Ars. 2016;50:109-113.
• Horne R, Weinman J. Self-regulation and self-management in asthma: Exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Heal. 2002;17(1):17-32.
• Şen ET, Berk ÖS, Sindel D. İlaç Uyumunu Bildirim Ölçeği’nin Türkçeye uyarlanması. İstanbul Tıp Fakültesi Derg. 2019;82(1):52–61.
• Nair PA, Vora RP, Jivani NB, Gandhi SS. A study of clinical profile and quality of life in patients with scabies at a rural tertiary care centre. Journal of Clinical and Diagnostic Research. 2016;10(10):1-5.
• Taylor S, Fischer K. Understanding the role of the Scabies mite microbiota in the development of novel control strategies. J Cell Immunol. 2021;3(2):122-127.
• Lopes MJ, Da Silva ET, Ca J, et al. Perceptions, attitudes and practices towards scabies in communities on the Bijagós Islands, Guinea-Bissau. Trans R Soc Trop Med Hyg. 2020;114(1):49-56.
• Srinivas S, Prithvi Raj K, Leelamohan PVR. Assessment of clinical profile and quality of life in scabies patients at a Tertiary Care Centre. Int J Heal Clin Res. 2021;4(2):124-128.
• Mitchell I, Bell S, Thean LJ, et al. Community perspectives on scabies , impetigo and mass drug administration in Fiji : A qualitative study. PLoS Negl Trop Dis. 2020;14(12):1-19.
• Trettin B, Lassen JA, Andersen F, Agerskov H. The journey of having scabies–A qualitative study. J Nurs Educ Pract. 2019;9(2):1-9.
• Alberfkani M, Mero W. Incidence of scabies and head lice and ˜eir associated risk factors among displaced people in Cham Mishko Camp, Zakho City, Duhok Province, Iraq. Polish J Microbiol. 2020;69(4):463-469.
• Faridi T, Munir A, Hassan S, Perveen I, Rana M. View of socio-demographic patterns, perceptions, prevalence and communicability of scabies in Islamabad, Pakistan. Life Sci J Pakistan. 2021;3(1):8-15.
• Reichert F, Schulz M, Mertens E, Lachmann R, Aebischer A. Reemergence of scabies driven by adolescents and young adults, Germany, 2009–2018. Emerg Infect Dis. 2021;6:1693-1696.
• Behera P, Munshi H, Kalkonde Y, Deshmukh M, Bang A. Control of scabies in a tribal community using mass screening and treatment with oral ivermectin -A cluster randomized controlled trial in Gadchiroli, India. PLoS Negl Trop Dis. 2021;15(4):e0009330.
• Chandler DJ, Fuller LC. A review of scabies: an ınfestation more than skin deep. Dermatology. 2019;235:79-90.
• Lake SJ, Engelman D, Sokana O, et al. Health-related quality of life impact of scabies in the Solomon Islands. Trans R Soc Trop Med Hyg. 2021;116: 148-156.